Here's an even better idea: Offer the Free six-month pricing in Germany. Basically, saying we reject your low-ball arbitrage price. We'd rather give it away for free than let patients die from MACE. this solves an inventory spoilage issue, maintains pricing leverage while resubmitting a new dossier, and gets patients "hooked" on VAZKEPA.